While endocrine therapies are very effective, de novo and acquired resistance frequently occurs over the course of therapy.8 The drugs used in the treatment of breast cancer include pharmacological agents for endocrine therapy, such as drugs that target HER2 and other signal molecules, and conventional chemotherapy. The gene discussed is ERBB2; the disease is breast carcinoma.